A study using CoSara Diagnostics' SARAGENE® HPV-HR Test in Gujarat, India, screened 625 women aged 30-60, identifying 20 high-risk HPV-positive cases. Despite mostly negative cytology results, follow-up biopsies found 12 women with high-grade cervical lesions or cervical cancer. This highlights the importance of molecular HPV testing in improving cervical cancer screening, especially where diagnostic access is limited. Co-Diagnostics aims to expand access to affordable molecular diagnostics across India and South Asia, with plans for further product development and awareness initiatives.
Co-Diagnostics' joint venture CoSara Diagnostics is noted here alongside health sector market data from Pluang. For readers following health stocks, as of Oct 29, 2026 19:12 WIB, 91 of 150 priced US health-sector stocks rose while 53 fell. Notable movers include BAX at USD 26.40 with a 3.69% increase and a typical hold time of 72 days, VRTX at USD 548.49 up 3.55% with a 56% sell order activity and 122 days hold time, and NVS at USD 161.10 rising 3.22% with 58% sell order activity and 84 days hold time.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
